First Quadrant’s NuVasive, Inc. NUVA Stock Holding History

First Quadrant’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-376	Closed	-$25K	–	607
2021 Q1	$25K	Sell	376 -2,460	-87%	-$148K	﹤0.01%	513
2020 Q4	$160K	Buy	2,836 +2,460	+654%	+$121K	0.02%	382
2020 Q3	$18K	Hold	376	–	–	﹤0.01%	591
2020 Q2	$21K	Hold	376	–	–	﹤0.01%	678
2020 Q1	$19K	Buy	+376	New	+$25.2K	﹤0.01%	597
2019 Q1	–	Sell	-2,478	Closed	-$123K	–	842
2018 Q4	$123K	Buy	+2,478	New	+$149K	0.01%	617
2013 Q3	–	Sell	-9,100	Closed	-$226K	–	816
2013 Q2	$226K	Buy	+9,100	New	+$199K	0.01%	525

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Quadrant's NUVA Position: Q2 2021 in Review

First Quadrant sold out of NuVasive, Inc. (NUVA) in Q2 2021, closing a stake of 376 shares — an estimated $25K sold.

First Quadrant first reported a position in NUVA in Q2 2013 and held it in 7 quarters. The position peaked at $226K in Q2 2013. 259 funds tracked by Wall St. Rank hold NUVA as of Q2 2021.

First Quadrant reported no remaining NuVasive, Inc. position as of Q2 2021 after selling out during the quarter.
First Quadrant sold 376 NuVasive, Inc. shares in Q2 2021, an estimated $25K.
First Quadrant first reported a position in NuVasive, Inc. in Q2 2013 and held it in 7 quarters.
First Quadrant's NuVasive, Inc. position peaked at $226K in Q2 2013.
259 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2021.

Based on First Quadrant's 13F filing for Q2 2021, filed 23 Jul 2021.